Human anti-murine immunoglobulin responses in patients receiving monoclonal antibody therapy.

No abstract is available for this paper.

• Publication year

  1985

• Venue

  Cancer Research

• Publication date

  1985-02-01

• Fields of study

  Medicine

• Identifiers
  PMID 3871353
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human anti-idiotype antibodies in cancer patients: Is the modulation of the immune response beneficial for the patient?

  1984cited by this paper
• Monoclonal antibody therapy of malignant melanoma: in vivo localization in cutaneous metastasis after intravenous administration.

  1984influential reference
• Effects of monoclonal antibody therapy in patients with chronic lymphocytic leukemia.

  1984influential reference
• Effects of monoclonal antibody immunotherapy on patients with gastrointestinal adenocarcinoma.

  1984cited by this paper
• Monoclonal antibody therapeutic trials in seven patients with T-cell lymphoma.

  1983cited by this paper
• Monoclonal antibodies in cancer therapy.

  1983cited by this paper
• Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody.

  1982cited by this paper
• Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody.

  1982cited by this paper
• Response of cutaneous T cell lymphoma to therapy with hybridoma monoclonal antibody.

  1981cited by this paper
• Serotherapy of acute lymphoblastic leukemia with monoclonal antibody.

  1981cited by this paper
• Production and characterization of monoclonal antibody to a melanoma specific glycoprotein.

  1981cited by this paper
• In vivo effects of murine hybridoma monoclonal antibody in a patient with T-cell leukemia.

  1981cited by this paper
• Human T cell antigens defined by monoclonal antibodies: the 65,000-dalton antigen of T cells (T65) is also found on chronic lymphocytic leukemia cells bearing surface immunoglobulin.

  1980cited by this paper
• Anti- -globulins in rheumatoid arthritis sera. 3. The reactivity of anti- -globulin rheumatoid factors with heterologous G-globulin.

  1972cited by this paper
• Anti- -globulins in rheumatoid arthritis sera. II. The reactivity of anti- -globulin rheumatoid factors with altered G-globulin.

  1971cited by this paper
• Antiglobulin factors in sera from patients with rheumatoid arthritis and normal subjects. Quantitative estimation in different immunoglobulin classes.

  1967cited by this paper

• Challenges and Insights in Absolute Quantification of Recombinant Therapeutic Antibodies by Mass Spectrometry: An Introductory Review

  2025cites this paper
• SITA: Predicting site-specific immunogenicity for therapeutic antibodies

  2025cites this paper
• Development and analytical performance of a new research use only (RUO) GP73 automated immunoassay

  2025cites this paper
• Obinutuzumab and Ofatumumab are More Effective Than Rituximab in the Treatment of Membranous Nephropathy Patients With Anti-Rituximab Antibodies

  2024cites this paper
• Humanization and characterization of an anti-ciguatoxin CTX3C monoclonal antibody.

  2024cites this paper
• Dose-Related Side Effects of Intravitreal Injections of Humanized Anti-Vascular Endothelial Growth Factor in Rats: Glial Cell Reactivity and Retinal Ganglion Cell Loss

  2024cites this paper
• Factors involved in the immunogenicity of biopharmaceutical products and mitigation strategies

  2023cites this paper
• Computational optimization of antibody humanness and stability by systematic energy-based ranking

  2023influential citation
• Coronavirus Vaccination: Spike Antibody Levels in Health Workers after Six Months—A Cross-Sectional Study

  2022cites this paper
• Retrospective analysis of the preparation and application of immunotherapy in cancer treatment (Review)

  2022cites this paper
• The Use of Antibody-Antibiotic Conjugates to Fight Bacterial Infections

  2022cites this paper
• Reliable energy-based antibody humanization and stabilization

  2022cites this paper
• Overview of monoclonal antibodies

  2021cites this paper
• The Carcinoembryonic Antigen (CEA): Past, Present, and Future [MJM 1997 3: 46-66]

  2020cites this paper
• Recombinant β-Glucocerebrosidase specific immunoaffinity ligands selected from phage-displayed combinatorial scFv libraries.

  2020cites this paper
• Antibody-Based Immunotherapy: Alternative Approaches for the Treatment of Metastatic Melanoma

  2020cites this paper
• Immunogenicity of TNF-Inhibitors

  2020cites this paper
• Advances in epidermal growth factor receptor specific immunotherapy: lessons to be learned from armed antibodies

  2020cites this paper
• The Molecular Mechanisms That Underlie the Immune Biology of Anti-drug Antibody Formation Following Treatment With Monoclonal Antibodies

  2020cites this paper
• The Carcinoembryonic Antigen (CEA): Past, Present, and Future

  2020cites this paper
• The Epitope-Specific Anti-human CD4 Antibody MAX.16H5 and Its Role in Immune Tolerance

  2019cites this paper
• Myocardial deformation imaging and prognostication in acute heart failure

  2019cites this paper
• Lessons learned from merging wet lab experiments with molecular simulation to improve mAb humanization

  2018cites this paper
• Anti-angiogenic effect of a humanized antibody blocking the Wnt/β-catenin signaling pathway.

  2018cites this paper
• Antibody–drug conjugates (ADCs) for cancer therapy: Strategies, challenges, and successes

  2018cites this paper
• Role of MCRP in the clinical management and the pathophysiology of the acute coronary syndromes

  2018influential citation
• Hersintuzumab: A novel humanized anti-HER2 monoclonal antibody induces potent tumor growth inhibition

  2018cites this paper
• Humanization and Simultaneous Optimization of Monoclonal Antibody.

  2018cites this paper
• Effect of an oxygen‐generating scaffold on the viability and insulin secretion function of porcine neonatal pancreatic cell clusters

  2018cites this paper
• Immune TB Antibody Phage Display Library as a Tool To Study B Cell Immunity in TB Infections

  2018cites this paper
• Nomenclature of humanized mAbs: Early concepts, current challenges and future perspectives

  2018cites this paper
• Optimization and qualification of the single molecule array digital immunoassay for IL-12p70 in plasma of cancer patients.

  2018cites this paper
• Generation and testing anti-influenza human monoclonal antibodies in a new humanized mouse model (DRAGA: HLA-A2. HLA-DR4. Rag1 KO. IL-2Rγc KO. NOD)

  2018cites this paper
• Antibody‐drug conjugates: Promising and efficient tools for targeted cancer therapy

  2018cites this paper
• Development of a novel T cell engaging antibody derivative for local PD-1/PD-L1 immune checkpoint blockade in acute myeloid leukemia

  2018cites this paper
• Overview of Monoclonal Antibody Therapies

  2018cites this paper
• Monoclonal antibodies in the detection and treatment of micrometastatic or minimal residual disease; an overview

  2018cites this paper
• The Interleukin-2 Receptor : A Target for Monoclonal Ant ibody Treatment of Human T-Cell Lymphotrophic Virus I-Induced Adult T-Cell Leukemia

  2017cites this paper
• Antibody- and Peptide-based Immunotherapies : Proof-of-concept and safety considerations

  2017cites this paper
• Humanization of JAA-F11, a Highly Specific Anti-Thomsen-Friedenreich Pancarcinoma Antibody and InVitro Efficacy Analysis

  2017cites this paper
• Recent Advances in Antibody-Drug Conjugates for Breast Cancer Treatment.

  2017cites this paper
• HUMANIZED ANT-PROSTATE STEM CELL ANTIGEN MONOCLONAL ANTIBODY

  2017cites this paper
• ROR1 as a target for cancer immunotherapy

  2017cites this paper
• Molecular imaging in drug development: Update and challenges for radiolabeled antibodies and nanotechnology.

  2017cites this paper
• Advances in the Isolation of Specific Monoclonal Rabbit Antibodies

  2017cites this paper
• Artefactual 25-OH vitamin D concentration in multiple myeloma

  2017cites this paper
• Collagen Sponge Functionalized with Chimeric Anti-BMP-2 Monoclonal Antibody Mediates Repair of Critical-Size Mandibular Continuity Defects in a Nonhuman Primate Model

  2017cites this paper
• The anti-tumor efficacy of 3C23K, a glyco-engineered humanized anti-MISRII antibody, in an ovarian cancer model is mainly mediated by engagement of immune effector cells

  2017cites this paper
• abYsis: Integrated Antibody Sequence and Structure-Management, Analysis, and Prediction.

  2017cites this paper
• Production of antigen-specific human IgGs by in vitro immunization

  2016cites this paper
• Radioimmunoguided Surgery: Intraoperative Radioimmunodetection for the Radioguided Localization and Resection of Tumors

  2016cites this paper
• Generation of Human Antibodies Against a Specific Peptide: a Novel Strategy Based on Human Cells.

  2016cites this paper
• Antibody–drug conjugates for targeted anticancer drug delivery

  2016cites this paper
• Processing and packaging

  2016cites this paper
• Bioanalytical qualification of clinical biomarker assays in plasma using a novel multi-analyte Simple Plex™ platform.

  2016cites this paper
• TRANSFECTION OF AN EXPRESSIVE CONSTRUCT INCLUDING IGG1 AND FV1 GENES IN OVARY CELL LINE FOR INFLIXIMAB EXPRESSION

  2016cites this paper
• Antibody humanization by molecular dynamics simulations—in‐silico guided selection of critical backmutations

  2016cites this paper
• Detecting tau in serum of transgenic animal models after tau immunotherapy treatment.

  2016cites this paper
• The History of Therapeutic Monoclonal Antibodies

  2016cites this paper
• Investigating the role of activated leukocyte cell adhesion molecule in vascular biology and its potential as a therapeutic target

  2016cites this paper
• Antibody–drug conjugates as novel anti-cancer chemotherapeutics

  2015cites this paper
• Man-made antibodies and immunoconjugates with desired properties: function optimization using structural engineering

  2015cites this paper
• Development of biologics for use in translational medicine

  2015cites this paper
• Inhibiting angiogenesis with human single-chain variable fragment antibody targeting VEGF.

  2015cites this paper
• Développement de fragments d’anticorps ciblant ZnT8 pour l’imagerie fonctionnelle des cellules bêta pancréatiques

  2015cites this paper
• Pharmacokinetic and pharmacodynamic challenges of Antibody-Directed Enzyme Prodrug Therapy (ADEPT)

  2014cites this paper
• Clinical Development of Antibody-Fusion Proteins for Cancer Therapy

  2014cites this paper
• Active Immunity Induced by Passive IgG Post-Exposure Protection against Ricin

  2014cites this paper
• Nonclinical Safety Assessment of Biotechnology‐Derived Products: Considerations and Challenges

  2014cites this paper
• The effect of antidrug antibodies on the sustainable efficacy of biologic therapies in rheumatoid arthritis: practical consequences

  2014cites this paper
• The epigenetic regulation of the EGF-receptor ligands Amphiregulin and Epiregulin and its impact on the outcome of EGFR-targeted therapies

  2014cites this paper
• Mammalian cell display technology coupling with AID induced SHM in vitro: an ideal approach to the production of therapeutic antibodies.

  2014cites this paper
• humMR1, a highly specific humanized single chain antibody for targeting EGFRvIII.

  2014cites this paper
• Étude du myélome multiple au travers de l'imagerie médicale

  2014cites this paper
• Humanization and simultaneous optimization of monoclonal antibody.

  2014cites this paper
• Alternative methods in toxicity testing: the current approach

  2014cites this paper
• Significance of weakly positive urine pregnancy tests

  2013cites this paper
• Radioimmunotherapy with 177Lu-DOTA-Rituximab: Final Results of a Phase I/II Study in 31 Patients with Relapsing Follicular, Mantle Cell, and Other Indolent B-Cell Lymphomas

  2013cites this paper
• Clinical application of the different cross-reactivities of anti-insulin antibodies to insulin lispro to evaluate endogenous insulin secretion.

  2013cites this paper
• Genetic engineering of recombinant anti-mycolic acid antibody fragments for use in tuberculosis diagnostics

  2013cites this paper
• STRUCTURAL AND FUNCTIONAL TRAITS OF NG2/CSPG4 PROTEOGLYCAN IN RELATION TO ITS ROLE IN TUMORS

  2013cites this paper
• Construction, expression and characterization of a single chain variable fragment antibody against human myostatin.

  2013cites this paper
• Novel antibodies targeting immune regulatory checkpoints for cancer therapy

  2013cites this paper
• Immunomodulatory Therapy of Solid Tumors : With a Focus on Monoclonal Antibodies

  2013cites this paper
• Production of a neutralizing mouse-human chimeric antibody against botulinum neurotoxin serotype E.

  2013cites this paper
• Targeted radionuclide therapy--an overview.

  2013cites this paper
• Construction and characterization of a new chimeric antibody against HER2.

  2013cites this paper
• MONOCLONAL ANTIBODIES WITH ADCC AND CDC ENHANCEMENT FOR THERAPY

  2013cites this paper
• Reactivity of Human IgM Binding Murine Monoclonal 6B6C1 (IgG2a) with Other Murine Monoclonal IgG Antibodies

  2013cites this paper
• Functionalization of scaffolds with chimeric anti-BMP-2 monoclonal antibodies for osseous regeneration.

  2013cites this paper
• Construction and characterization of a new chimeric 1 antibody against HER 2

  2013cites this paper
• Development, Characterization and Validation of Trastuzumab-Modified Gold Nanoparticles for Molecularly Targeted Radiosensitization of Breast Cance

  2013cites this paper
• Intracellular delivery of therapeutic antibodies

  2012cites this paper
• Is there need for radioimmunotherapy? results of a phase I/II study in patients with indolent B-cell lymphomas using lutetium-177-DOTA-rituximab.

  2012cites this paper
• Étude rétrospective de l'effet de l'Infliximab sur la masse corporelle au cours des rhumatismes inflammatoires chroniques

  2012cites this paper
• Characterization of neutralizing mouse‐human chimeric and shuffling antibodies against botulinum neurotoxin A

  2012cites this paper
• Production et caractérisation d’anticorps polyclonaux et monoclonaux ciblant les récepteurs des endothélines en vue d’une immunothérapie des cancers

  2012cites this paper
• Interpretation of Hormone Levels in Older Patients: Points for Consideration

  2012cites this paper
• Pretargeting agents and At-211-labeled effector molecules: Synthesis and preclinical evaluation for pretargeted alpha-radioimmunotherapy.

  2012cites this paper
• Molecular engineering of antibodies for therapeutic and diagnostic purposes

  2012cites this paper